Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kura Oncology (KURA)

Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kura Oncology 4930 DIRECTORS PLACE SUITE 500 SAN DIEGO CA 92121 USA

www.kuraoncology.com Employees: 192 P: 858-500-8800

Sector:

Medical

Description:

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.

Key Statistics

Overview:

Market Capitalization, $K 676,130
Enterprise Value, $K 461,200
Shares Outstanding, K 87,018
Float, K 81,449
% Float 93.60%
Short Interest, K 12,312
Short Float 14.15%
Days to Cover 8.64
Short Volume Ratio 0.64
% of Insider Shareholders 6.40%

Financials:

Annual Sales, $ 53,880 K
Annual Net Income, $ -173,980 K
Last Quarter Sales, $ 20,750 K
Last Quarter Net Income, $ -74,120 K
EBIT, $ -293,710 K
EBITDA, $ -306,000 K

Growth:

1-Year Return -10.81%
3-Year Return -36.10%
5-Year Return -76.81%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -33.77%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.85 on 11/04/25
Next Earnings Date 02/25/26 [--]
Earnings Per Share ttm -2.48
EPS Growth vs. Prev Qtr -13.33%
EPS Growth vs. Prev Year -34.92%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

KURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -65.42%
Return-on-Assets % -30.59%
Profit Margin % -322.90%
Debt/Equity 0.04
Price/Sales 6.59
Price/Cash Flow N/A
Price/Book 2.80
Book Value/Share 2.79
Interest Coverage -105.15
60-Month Beta 0.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar